Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease. Painchart C, Brabant S, Duveau N, Nachury M, et al. Dig Dis Sci 2020;65:1445-1452.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Painchart C, Brabant S, Duveau N, Nachury M, et al. Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease. Dig Dis Sci 2020;65:1445-1452.
PMID: 31599389